Wynn Capital
ABBV icon

Wynn Capital’s AbbVie ABBV Stock Holding History

Wynn Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.45M Sell
9,383
-5
-0.1% -$1.28K 1.09% 27
2026
Q2 		$2.36M Buy
9,388
+70
+0.8% +$15.1K 1.05% 30
2026
Q1 		$2.03M Sell
9,318
-44
-0.5% -$9.8K 1.04% 30
2025
Q4 		$2.14M Sell
9,362
-220
-2% -$50.1K 1.04% 27
2025
Q3 		$2.22M Hold
9,582
– – 1.08% 27
2025
Q2 		$1.78M Sell
9,582
-13
-0.1% -$2.42K 0.95% 29
2025
Q1 		$2.01M Buy
9,595
+1,085
+13% +$211K 1.19% 23
2024
Q4 		$1.51M Sell
8,510
-10
-0.1% -$1.84K 0.95% 31
2024
Q3 		$1.68M Buy
8,520
+170
+2% +$31.7K 1.1% 27
2024
Q2 		$1.43M Buy
8,350
+130
+2% +$21.5K 1.06% 29
2024
Q1 		$1.5M Sell
8,220
-204
-2% -$35.2K 1.16% 30
2023
Q4 		$1.31M Buy
+8,424
New +$1.23M 1.07% 31

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Wynn Capital's ABBV Position: Q3 2026 in Review

Wynn Capital reduced its AbbVie (ABBV) stake by 0.05% in Q3 2026, selling an estimated $1.28K and leaving 9,383 shares worth $2.45M. The position accounts for 1.09% of the portfolio, ranked #27.

Wynn Capital first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 2,685 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Wynn Capital held 9,383 shares of AbbVie worth $2.45M as of Q3 2026.
  • Wynn Capital sold 5 AbbVie shares in Q3 2026, an estimated $1.28K.
  • AbbVie made up 1.09% of Wynn Capital's portfolio in Q3 2026, its #27 holding.
  • Wynn Capital first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 2,685 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Wynn Capital's 13F filing for Q3 2026, filed 13 Oct 2026.